Solid forms of (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine hydrochloride, in particular crystalline forms and/or amorphous forms thereof, pharmaceutical compositions and medicaments containing these solid forms, the use of these solid forms, and a process for obtaining such solid forms.
(1R,4R)-6'-
氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[
环己烷-1,1'-
吡喃[3,4,b]
吲哚]-4-胺盐酸盐的固态形式,特别是其晶体形式和/或非晶形式,包括这些固态形式的药物组合物和药物,这些固态形式的用途以及获得这些固态形式的过程。